Fast Company September 27, 2021
Ruth Reader

Neuroscientist Sheila Nirenberg’s breakthrough neural code is restoring sight in humans and expanding visual capabilities in computing, but some of her academic peers would like to see more transparency in her data.

On the eighth night of Hanukkah last year, Barry Honig saw light. He could see the shape of the menorah, the flames like fuzzy buds at the top of long sticks.

Honig owns and operates two businesses but hadn’t been able to see a menorah for 20 years. In his younger years, he could discern a brunette from a blonde or see the sun shimmering on a lake. But by his thirties, his ability to see detail had started to fade.

He was born with a retinal disorder...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
FDA Update for Week of April 22, 2024: Second Gene Therapy for Hemophilia B
Why Conflicts Of Interest May Not Be As Bad As You Think (And Besides We All Have Them!)
11 drugs now in shortage
AbbVie tries to reassure investors on Humira biosimilar threat
Pfizer scores FDA nod for hemophilia B gene therapy, will charge $3.5M per dose

Share This Article